Free Trial
NASDAQ:BWAY

Brainsway (BWAY) Stock Price, News & Analysis

Brainsway logo
$15.60 -0.09 (-0.54%)
As of 10:20 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Brainsway Stock (NASDAQ:BWAY)

Key Stats

Today's Range
$15.25
$15.68
50-Day Range
$11.47
$15.90
52-Week Range
$7.06
$16.00
Volume
11,658 shs
Average Volume
55,833 shs
Market Capitalization
$294.75 million
P/E Ratio
59.98
Dividend Yield
N/A
Price Target
$18.00
Consensus Rating
Buy

Company Overview

Brainsway Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
74th Percentile Overall Score

BWAY MarketRank™: 

Brainsway scored higher than 74% of companies evaluated by MarketBeat, and ranked 283rd out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Brainsway has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Brainsway has only been the subject of 2 research reports in the past 90 days.

  • Read more about Brainsway's stock forecast and price target.
  • Earnings Growth

    Earnings for Brainsway are expected to grow by 100.00% in the coming year, from $0.08 to $0.16 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Brainsway is 59.68, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 272.02.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Brainsway is 59.68, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 82.61.

  • Price to Book Value per Share Ratio

    Brainsway has a P/B Ratio of 4.27. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Brainsway's valuation and earnings.
  • Percentage of Shares Shorted

    0.35% of the outstanding shares of Brainsway have been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently decreased by 20.07%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Brainsway does not currently pay a dividend.

  • Dividend Growth

    Brainsway does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.35% of the outstanding shares of Brainsway have been sold short.
  • Short Interest Ratio / Days to Cover

    Brainsway has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Brainsway has recently decreased by 20.07%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Brainsway has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Brainsway this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for BWAY on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • MarketBeat Follows

    3 people have added Brainsway to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Brainsway insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    19.00% of the stock of Brainsway is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 30.11% of the stock of Brainsway is held by institutions.

  • Read more about Brainsway's insider trading history.
Receive BWAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Brainsway and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BWAY Stock News Headlines

HC Wainwright Reaffirms "Buy" Rating for Brainsway (NASDAQ:BWAY)
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
BrainsWay Falters on New Investment
See More Headlines

BWAY Stock Analysis - Frequently Asked Questions

Brainsway's stock was trading at $9.43 at the start of the year. Since then, BWAY shares have increased by 63.0% and is now trading at $15.3750.

Brainsway Ltd. Sponsored ADR (NASDAQ:BWAY) issued its quarterly earnings results on Wednesday, August, 13th. The company reported $0.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.07 by $0.03. The business had revenue of $12.63 million for the quarter, compared to analysts' expectations of $12.34 million. Brainsway had a trailing twelve-month return on equity of 8.97% and a net margin of 11.60%.
Read the conference call transcript
.

Brainsway (BWAY) raised $30 million in an IPO on Wednesday, April 17th 2019. The company issued 2,500,000 shares at a price of $11.94 per share. Cantor acted as the underwriter for the IPO.

Brainsway's top institutional shareholders include Phoenix Financial Ltd. (1.92%), Acadian Asset Management LLC (1.77%), ARK Investment Management LLC (1.06%) and Huntleigh Advisors Inc. (0.41%).

Shares of BWAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Brainsway investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Novo Nordisk A/S (NVO) and AppLovin (APP).

Company Calendar

Last Earnings
8/13/2025
Today
9/04/2025
Next Earnings (Estimated)
11/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:BWAY
CIK
1505065
Fax
N/A
Employees
120
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$17.00
Potential Upside/Downside
+14.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.26
Trailing P/E Ratio
60.31
Forward P/E Ratio
196.00
P/E Growth
N/A
Net Income
$2.92 million
Net Margins
11.60%
Pretax Margin
12.66%
Return on Equity
8.97%
Return on Assets
5.65%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.51
Quick Ratio
3.34

Sales & Book Value

Annual Sales
$41.02 million
Price / Sales
7.22
Cash Flow
$0.25 per share
Price / Cash Flow
62.40
Book Value
$3.60 per share
Price / Book
4.36

Miscellaneous

Outstanding Shares
18,900,000
Free Float
15,311,000
Market Cap
$296.35 million
Optionable
Not Optionable
Beta
1.34

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:BWAY) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners